Industry and News Fidaxomicin Market 点击阅读
  • 评论

Industry and News

Fidaxomicin Market

出版日期 / “商业, 健康与健身” / 语言—English / 4页
Global Fidaxomicin Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Fidaxomicin is also termed as Difimicin, or Tiacumicin B, or Lipiarmicin, or Lipiarrmycin, or Lipiarmycin. It is a macrolide antibacterial drug specified for the treatment of Clostridium Difficile-Associated Diarrhea. The antibiotic Fidaxomicin drug kills bacteria in the intestines. 更多
Industry And News helps to understand the characteristics and preferences of customers and monitor the level of competition in market. 更多
免费订阅

“ Industry and News”的其他出版物

查看所有出版物